Detailed price information for Transcode Therapeutics Inc (RNAZ-Q) from The Globe and Mail including charting and trades.
TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA for the ...
XDA Developers on MSN
I finally ditched Plex for Jellyfin, and I’m never going back
In Plex’s defense, I can opt out of disclosing certain information. But I’m still not comfortable sending any data to an ...
If you're looking to break away from third-party file and directory storage, this NAS from Terramaster might be just what you need.
BOSTON - TransCode Therapeutics, Inc. (NASDAQ:RNAZ), a micro-cap biotech company with a market capitalization of just $7.91 million, and Quantum Leap Healthcare Collaborative announced Thursday a ...
TransCode acquires 100% of the issued and outstanding interests of Polynoma from CK Life Sciences Concurrent equity investment of $25 Million from CK Life Sciences into TransCode TransCode expands its ...
BOSTON, May 5, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company committed to more effectively treating cancer using RNA ...
BOSTON, April 21, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ ) ("TransCode" or the "Company"), the RNA Oncology CompanyTM committed to more effectively treating cancer using RNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback